Postmenopausal breast cancer: a best endocrine strategy?
- PMID: 26211823
- DOI: 10.1016/S0140-6736(15)61206-5
Postmenopausal breast cancer: a best endocrine strategy?
Comment on
-
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.Lancet. 2015 Oct 3;386(10001):1341-1352. doi: 10.1016/S0140-6736(15)61074-1. Epub 2015 Jul 23. Lancet. 2015. PMID: 26211827
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical